Literature DB >> 22102851

H. pylori-Induced Higher C-Reactive Protein in Obese African Americans.

Nuzhat R Siddiqui1, W Timothy Garvey, Mohammad A Khaled.   

Abstract

African Americans are more susceptible to develop insulin resistance, obesity, Type 2 Diabetes, and coronary heart disease (CHD), and systemic inflammation is central to the pathophysiology of these chronic diseases. African Americans are also more likely to contract H. pylori (cagA) infections during their childhood. However, the contribution of H. pylori infection to the degree of overall systemic inflammation in these chronic diseases is not known. Therefore, we studied 46 apparently healthy African Americans, over 40 years of age who were, infected with H. pylori (cagA). These volunteers were assessed at baseline and after treatment with triple regimen drug therapy to eradicate H. pylori. All but 3 subjects were found to be free of this infection by urea breath test (UBT) after the treatment period. No hyperhomocysteinemia was found in these subjects and there were no significant changes in the level of homocysteine (tHcy), folate and B(12); however, CRP levels measured by high sensitivity assay showed a significant (p=0.02) decrease 2 months after the eradication. We further stratified CRP values according to the BMI < 27 and > 27. There was more profound reduction in CRP in the more obese group (i.e., BMI>27) from 54.26 ± 23.67 to 18.73 ± 17.39 mg/l (p=0.01), compared with the leaner subjects in whom CRP decreases from 8.88 ± 6.23 to 4.94 ± 6.21 mg/L (p=0.04), after eradication of the H. pylori (cagA) infection. The level of CRP, however, remained significantly higher in the obese subjects even after the eradication of this infection, indicative of a smaller residual influence of adiposity on CRP. Thus, a major component of systemic inflammation in African Americans may be attributable to chronic H. pylori infection.

Entities:  

Year:  2009        PMID: 22102851      PMCID: PMC3218794          DOI: 10.1016/j.artres.2009.01.004

Source DB:  PubMed          Journal:  Artery Res        ISSN: 1872-9312            Impact factor:   0.597


  18 in total

1.  Hyperhomocysteinemia due to Helicobacter pylori?

Authors:  Mohammad A Khaled; Phillip E Cornwell
Journal:  Atherosclerosis       Date:  2004-01       Impact factor: 5.162

Review 2.  Roles of infectious agents in atherosclerosis and restenosis: an assessment of the evidence and need for future research.

Authors:  P Libby; D Egan; S Skarlatos
Journal:  Circulation       Date:  1997-12-02       Impact factor: 29.690

Review 3.  Atherosclerosis and inflammation.

Authors:  John A Farmer; Guillermo Torre-Amione
Journal:  Curr Atheroscler Rep       Date:  2002-03       Impact factor: 5.113

4.  Helicobacter pylori infection and mortality from ischaemic heart disease: negative result from a large, prospective study.

Authors:  N J Wald; M R Law; J K Morris; A M Bagnall
Journal:  BMJ       Date:  1997-11-08

5.  Infectious risk factors for atherosclerotic vascular disease in hemodialysis patients--Chlamydia pneumoniae but not Helicobacter pylori or cytomegalovirus is associated with increased C-reactive protein.

Authors:  Sabine C Wolf; Bernhard R Brehm; Oliver Mayer; Stefan Jürgens; Georg Schultze; Teut Risler
Journal:  Ren Fail       Date:  2004-05       Impact factor: 2.606

6.  Helicobacter pylori virulence factors--one part of a big picture.

Authors:  Michael Höcker; Peter Hohenberger
Journal:  Lancet       Date:  2003-10-11       Impact factor: 79.321

7.  Helicobacter pylori recurrence after successful eradication: 5-year follow-up in the United States.

Authors:  M Z Abu-Mahfouz; V M Prasad; P Santogade; A F Cutler
Journal:  Am J Gastroenterol       Date:  1997-11       Impact factor: 10.864

8.  Obesity is the major determinant of elevated C-reactive protein in subjects with the metabolic syndrome.

Authors:  D Aronson; P Bartha; O Zinder; A Kerner; W Markiewicz; O Avizohar; G J Brook; Y Levy
Journal:  Int J Obes Relat Metab Disord       Date:  2004-05

9.  Seroepidemiology of Helicobacter pylori infection in India. Comparison of developing and developed countries.

Authors:  D Y Graham; E Adam; G T Reddy; J P Agarwal; R Agarwal; D J Evans; H M Malaty; D G Evans
Journal:  Dig Dis Sci       Date:  1991-08       Impact factor: 3.199

10.  Prospective analysis of the association of infection with CagA bearing strains of Helicobacter pylori and coronary heart disease.

Authors:  R K Singh; A D McMahon; H Patel; C J Packard; B J Rathbone; N J Samani
Journal:  Heart       Date:  2002-07       Impact factor: 5.994

View more
  3 in total

1.  Helicobacter pylori Infection and Inflammation: Implication for the Pathophysiology of Diabetes and Coronary Heart Disease in Asian Indians.

Authors:  M Afzalur Rahman; Mark B Cope; Shafique A Sarker; W Timothy Garvey; Habib S Chaudhury; Mohammad A Khaled
Journal:  J Life Sci       Date:  2009-07

Review 2.  The effect of Helicobacter pylori eradication on C-reactive protein: results from a meta-analysis.

Authors:  Jun Watanabe; Kazuhiko Kotani
Journal:  Arch Med Sci       Date:  2021-03-21       Impact factor: 3.707

3.  Association of Helicobacter pylori infection with coronary artery disease: is Helicobacter pylori a risk factor?

Authors:  Jamshid Vafaeimanesh; Seyyed Fakhroldin Hejazi; Vahid Damanpak; Mostafa Vahedian; Mohammadamin Sattari; Mohammadreza Seyyedmajidi
Journal:  ScientificWorldJournal       Date:  2014-01-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.